Retrospective Analysis to Describe Patient Profiles, Current Treatment Patterns and Economic Burden for Asthma Patients in UAE. A descriptive analysis of the asthma patient population in the Emirate of Dubai with respect to healthcare resource utilization, costs, and asthma-related treatment pattern

Trial Identifier: D2287R00139
Sponsor: AstraZeneca
NCTID:: NCT03963141
Start Date: August 2019
Primary Completion Date: October 2022
Study Completion Date: October 2022
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
United Arab Emirates Dubai, United Arab Emirates